Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate and Atorvastatin in Renal Cell Carcinoma
NCT00490698Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2006
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in renal cell carcinoma (RCC), sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2006; status: completed.
02
Drugs
atorvastatin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00490698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490698.